Alpha 2.0
Login Register
» Articles » PMID: 17135458

Self-reported Health in People with Parkinson's Disease Left Untreated at Diagnosis

Overview
Journal J Neurol Neurosurg Psychiatry
Publisher BMJ Publishing Group
Specialties Neurology
Neurosurgery
Psychiatry
Date 2006 Dec 1
PMID 17135458
Citations 2
Authors
Peter Hagell
Affiliations
Soon will be listed here.
Citing Articles

Poly(acrylic acid)/Poly(vinyl alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo Studies.

Li Y, Vora L, Wang J, Sabri A, Graham A, McCarthy H Pharmaceutics. 2024; 16(5).

PMID: 38794339 PMC: 11125810. DOI: 10.3390/pharmaceutics16050676.

Testing the SF-36 in Parkinson's disease. Implications for reporting rating scale data.

Hagell P, Tornqvist A, Hobart J J Neurol. 2008; 255(2):246-54.

PMID: 18204806 DOI: 10.1007/s00415-008-0708-y.

References
1.
Marras C, Lang A . Outcome measures for clinical trials in Parkinson's disease: achievements and shortcomings. Expert Rev Neurother. 2005; 4(6):985-93. DOI: 10.1586/14737175.4.6.985. View
2.
Hobart J . Rating scales for neurologists. J Neurol Neurosurg Psychiatry. 2003; 74 Suppl 4:iv22-iv26. PMC: 1765638. DOI: 10.1136/jnnp.74.suppl_4.iv22. View
3.
Reichmann H, BOAS J, MacMahon D, Myllyla V, Hakala A, Reinikainen K . Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations. Acta Neurol Scand. 2004; 111(1):21-8. DOI: 10.1111/j.1600-0404.2004.00363.x. View
4.
Grosset D, Taurah L, Burn D, MacMahon D, Forbes A, Turner K . A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis. J Neurol Neurosurg Psychiatry. 2006; 78(5):465-9. PMC: 2117846. DOI: 10.1136/jnnp.2006.098327. View
5.
Schapira A, Obeso J . Timing of treatment initiation in Parkinson's disease: a need for reappraisal?. Ann Neurol. 2006; 59(3):559-62. DOI: 10.1002/ana.20789. View